Glycopyrrolate Injection
Product Images NDC 71872-7289

2 FDA label images from Medical Purchasing Solutions, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Glycopyrrolate Injection Usp 1)

Structure (Glycopyrrolate Injection Usp 1)
Chemical structure of Glycopyrrolate showing the molecular arrangement including a bicyclic ring, ester linkage, and a quaternary ammonium group associated with a bromide ion.*
FDA Label Image

Glyclabel (Glyclabel)

Glyclabel (Glyclabel)
Label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) multiple dose vial, intended for intramuscular or intravenous administration. The label indicates one vial per package, includes a barcode, lot number, and expiration date. It notes the product contains benzyl alcohol preservative and is not for use in newborns. Manufactured by Amneal Pharmaceuticals and repackaged by Medical Purchasing Solutions, Scottsdale, AZ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.